This fully updated revision of the well-received first edition continues to provide a clear, comprehensive and up-to-date account of the role of lipid management in the prevention of coronary heart disease. Appropriate for the clinician managing lipid problems in either the primary or secondary care setting, the well-respected author team consider all aspects of screening, diagnosis and risk assessment, and management. The science underlying lipid metabolism is put into context for the practising physician, including recent developments in inflammation, plaque biology and the transition to serious events. Risk factor modification, including lifestyle change and cholesterol lowerinig by diet and medication are discussed fully. Landmark clinical trials, and the messages that can be drawn from them, are highlighted throughout. The practical focus is maintained through the consideration of specific patient groups demonstrating particular clinical importance, management difficulties or highlighting areas of current controversy. With a balanced, readable style and clear explanatory illustrations, this second edition provides invaluable advice for primary care and specialist clinicians, whether in training or in practice, in the management of lipid disorders and the prevention of cardiovascular events.
Rezensionen / Stimmen
With a balanced, readable style and clear explanatory illustrations, this second edition of Clinicians' Guide to Lipids and Coronary Heart Disease provides invaluable advice for primary care and specialist clinicians, whether in training or in practice, in the management of lipid disorders and the prevention of cardiovascular events.
CAB Abstracts
This is an excellent book addressing a key issue of considerable current interest.
Current Medical Research and Opinion Journal
Reihe
Auflage
Sprache
Verlagsort
Verlagsgruppe
Zielgruppe
Für höhere Schule und Studium
Für Beruf und Forschung
Editions-Typ
Illustrationen
84 colour line, 32 colour HT
Maße
Höhe: 248 mm
Breite: 191 mm
ISBN-13
978-0-340-76408-4 (9780340764084)
Copyright in bibliographic data and cover images is held by Nielsen Book Services Limited or by the publishers or by their respective licensors: all rights reserved.
Schweitzer Klassifikation
D.J. Betteridge is Professor of Endocrinology and Metabolism at University College London and Honorary Consultant Physician at UCL Hospitals NHS Trust, The Middlesex Hospital, London, UK. J.M. Morrell is both a family doctor and a hospital practitioner with an interest in CHD prevention.
Part 1 Background
Lipid and lipoprotein metabolism - the basics
Epidemiology
Part 2 Screening and Assessment
Diagnosis
Screening
Risk factors and their assessment
Part 3 Intervention
Non-lipid risk factor modification
Diet
Lipid lowering drugs
Lipid lowering trials
Part 4 Practical considerations and special areas
Meeting the challenge
Special areas
Economic aspects
Case studies.